Literature DB >> 8662649

Characterization of a protein kinase that phosphorylates serine 189 of the mitogen-activated protein kinase homolog ERK3.

M Cheng1, E Zhen, M J Robinson, D Ebert, E Goldsmith, M H Cobb.   

Abstract

A novel protein kinase activity present in nuclear and cytosolic extracts has been identified and partially purified as a consequence of its tight binding to and phosphorylation of the extracellular signal-regulated protein kinase (ERK) 3. This novel protein kinase is inactivated by treatment with phosphoprotein phosphatase 2A. The ERK3 protein kinase was immunologically distinct from mitogen-activated protein (MAP) kinase/ERK kinases (MEK) 1 and 2 which phosphorylate the ERK3-related MAP kinases ERK1 and ERK2. This ERK3 kinase phosphorylated a single site on ERK3, Ser189, comparable to Thr183, one of the two activating phosphorylation sites of ERK2. To test the specificity of the ERK3 kinase, mutants of ERK3 and ERK2 were made in which the phosphorylated residues were exchanged. The double mutant S189T,G191Y ERK3, in which the phosphorylated residues from ERK2 replaced the comparable residues in ERK3, was phosphorylated by the ERK3 kinase but only on threonine. The ERK3 kinase did not phosphorylate ERK2 or ERK2 mutants. These findings indicate that although the ERK3 kinase is highly specific for ERK3, it does not recognize tyrosine, a feature that distinguishes it from MEKs that phosphorylate other ERK/MAP kinase family members.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662649     DOI: 10.1074/jbc.271.20.12057

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Cloning and characterization of mouse extracellular-signal-regulated protein kinase 3 as a unique gene product of 100 kDa.

Authors:  B Turgeon; M K Saba-El-Leil; S Meloche
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK.

Authors:  J L Swantek; M H Cobb; T D Geppert
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Comprehensive quantitative comparison of the membrane proteome, phosphoproteome, and sialiome of human embryonic and neural stem cells.

Authors:  Marcella Nunes Melo-Braga; Melanie Schulz; Qiuyue Liu; Andrzej Swistowski; Giuseppe Palmisano; Kasper Engholm-Keller; Lene Jakobsen; Xianmin Zeng; Martin Røssel Larsen
Journal:  Mol Cell Proteomics       Date:  2013-10-30       Impact factor: 5.911

4.  Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway.

Authors:  Paul Déléris; Matthias Trost; Ivan Topisirovic; Pierre-Luc Tanguay; Katherine L B Borden; Pierre Thibault; Sylvain Meloche
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

Review 5.  Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Authors:  Marie Cargnello; Philippe P Roux
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

6.  Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity.

Authors:  Alina De la Mota-Peynado; Jonathan Chernoff; Alexander Beeser
Journal:  J Biol Chem       Date:  2011-02-11       Impact factor: 5.157

7.  Precisely ordered phosphorylation reactions in the p38 mitogen-activated protein (MAP) kinase cascade.

Authors:  John M Humphreys; Alexander T Piala; Radha Akella; Haixia He; Elizabeth J Goldsmith
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

8.  Scaffolding by ERK3 regulates MK5 in development.

Authors:  Stefanie Schumacher; Kathrin Laass; Shashi Kant; Yu Shi; Axel Visel; Achim D Gruber; Alexey Kotlyarov; Matthias Gaestel
Journal:  EMBO J       Date:  2004-11-11       Impact factor: 11.598

9.  A novel quinoline, MT477: suppresses cell signaling through Ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma cell lines.

Authors:  Piotr Jasinski; Brandon Welsh; Jorge Galvez; David Land; Pawel Zwolak; Lori Ghandi; Kaoru Terai; Arkadiusz Z Dudek
Journal:  Invest New Drugs       Date:  2007-10-24       Impact factor: 3.850

10.  N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome.

Authors:  Philippe Coulombe; Geneviève Rodier; Eric Bonneil; Pierre Thibault; Sylvain Meloche
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.